CELC
Price
$11.97
Change
+$0.13 (+1.10%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
448.72M
42 days until earnings call
KANT
Price
$0.30
Change
+$0.02 (+7.14%)
Updated
Jun 25 closing price
Capitalization
4.02M
Interact to see
Advertisement

CELC vs KANT

Header iconCELC vs KANT Comparison
Open Charts CELC vs KANTBanner chart's image
Celcuity
Price$11.97
Change+$0.13 (+1.10%)
Volume$4.04K
Capitalization448.72M
Kineta
Price$0.30
Change+$0.02 (+7.14%)
Volume$44.11K
Capitalization4.02M
CELC vs KANT Comparison Chart in %
Loading...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CELC vs. KANT commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a Buy and KANT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (CELC: $11.85 vs. KANT: $0.30)
Brand notoriety: CELC and KANT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELC: 73% vs. KANT: 237%
Market capitalization -- CELC: $448.72M vs. KANT: $4.02M
CELC [@Biotechnology] is valued at $448.72M. KANT’s [@Biotechnology] market capitalization is $4.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELC’s FA Score shows that 0 FA rating(s) are green whileKANT’s FA Score has 1 green FA rating(s).

  • CELC’s FA Score: 0 green, 5 red.
  • KANT’s FA Score: 1 green, 4 red.
According to our system of comparison, CELC is a better buy in the long-term than KANT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELC’s TA Score shows that 3 TA indicator(s) are bullish.

  • CELC’s TA Score: 3 bullish, 5 bearish.

Price Growth

CELC (@Biotechnology) experienced а +0.34% price change this week, while KANT (@Biotechnology) price change was +10.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.00%. For the same industry, the average monthly price growth was +32.55%, and the average quarterly price growth was +15.13%.

Reported Earning Dates

CELC is expected to report earnings on Aug 07, 2025.

KANT is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+2.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CELC($449M) has a higher market cap than KANT($4.03M). CELC YTD gains are higher at: -9.473 vs. KANT (-15.108). KANT has higher annual earnings (EBITDA): -20.45M vs. CELC (-114.96M). CELC has more cash in the bank: 206M vs. KANT (900K). KANT has less debt than CELC: KANT (710K) vs CELC (98.7M). CELC (0) and KANT (0) have equivalent revenues.
CELCKANTCELC / KANT
Capitalization449M4.03M11,155%
EBITDA-114.96M-20.45M562%
Gain YTD-9.473-15.10863%
P/E RatioN/AN/A-
Revenue00-
Total Cash206M900K22,889%
Total Debt98.7M710K13,901%
FUNDAMENTALS RATINGS
CELC vs KANT: Fundamental Ratings
CELC
KANT
OUTLOOK RATING
1..100
658
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
27
Undervalued
PROFIT vs RISK RATING
1..100
89100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
4864
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KANT's Valuation (27) in the null industry is in the same range as CELC (50) in the Miscellaneous Commercial Services industry. This means that KANT’s stock grew similarly to CELC’s over the last 12 months.

CELC's Profit vs Risk Rating (89) in the Miscellaneous Commercial Services industry is in the same range as KANT (100) in the null industry. This means that CELC’s stock grew similarly to KANT’s over the last 12 months.

CELC's SMR Rating (98) in the Miscellaneous Commercial Services industry is in the same range as KANT (100) in the null industry. This means that CELC’s stock grew similarly to KANT’s over the last 12 months.

CELC's Price Growth Rating (48) in the Miscellaneous Commercial Services industry is in the same range as KANT (64) in the null industry. This means that CELC’s stock grew similarly to KANT’s over the last 12 months.

CELC's P/E Growth Rating (100) in the Miscellaneous Commercial Services industry is in the same range as KANT (100) in the null industry. This means that CELC’s stock grew similarly to KANT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CELC
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 23 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYFIX102.52N/A
N/A
Rydex Financial Services Inv
PCOTX18.51N/A
N/A
Victory Pioneer Core Equity C
VNVYX23.93N/A
N/A
Natixis Vaughan Nelson Mid Cap Y
STMSX22.68N/A
N/A
SEI Tax-Managed Small/Mid Cap F (SIMT)
VTSIX89.16N/A
N/A
Vanguard Tax-Managed Small Cap I

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been loosely correlated with COGT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CELC jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
-2.47%
COGT - CELC
48%
Loosely correlated
-2.35%
CCCC - CELC
46%
Loosely correlated
-1.28%
ATXS - CELC
45%
Loosely correlated
-1.91%
TRDA - CELC
45%
Loosely correlated
-0.28%
RXRX - CELC
45%
Loosely correlated
-1.15%
More

KANT and

Correlation & Price change

A.I.dvisor indicates that over the last year, KANT has been loosely correlated with MDGL. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if KANT jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KANT
1D Price
Change %
KANT100%
+6.66%
MDGL - KANT
62%
Loosely correlated
-2.58%
SLNO - KANT
45%
Loosely correlated
+1.92%
VKTX - KANT
35%
Loosely correlated
+0.52%
CELC - KANT
34%
Loosely correlated
-2.47%
MDWD - KANT
29%
Poorly correlated
-0.10%
More